Skip to content
Screener

RxSight, Inc. RXST Q2 2026 earnings

Reported August 5, 2026 · After market close

Revenue$33.7MBeat by $1.2M
EPS-$0.29Beat by $0.04
Revenue estimate$32.5M
EPS estimate-$0.33
“It is a privilege to join RxSight and to work alongside the talented team that pioneered an entirely new category in cataract surgery with the only commercially available IOL platform that enables physicians to adjust and personalize vision after surgery. The opportunity ahead is significant, and our immediate priority is to strengthen commercial execution, deepen adoption across our installed base and translate the value of adjustability into durable growth. To support those priorities, I have commenced a comprehensive review of the business. While underlying trends remain generally consistent with our prior expectations, withdrawing 2026 guidance gives us the flexibility to establish the right operating plan and focus our resources on the core business, our pipeline and the Alcon collaboration.”
Aziz Mottiwala

Next report

Nov 4, 2026 (in 2 months)
Revenue estimate$27.2M
EPS estimate-$0.29

Financials

Q2 2026

Income statement

See full
Revenue$33.7M+0.3%
Operating income-$13.8M+1.7%
Net income-$12.1M-2.6%
EPS (diluted)-$0.290.0%

Balance sheet

See full
Cash & equivalents$13.4M-66.9%
Total debt$10.6M-9.7%
Total equity$263.3M-5.3%
Total assets$352.7M+14.1%

Cash flow

See full
Operating cash flow-$9.5M-118%
CapEx$2.0M+27.3%
Free cash flow-$11.5M-94.4%

Valuation & ratios

Valuation

as of 09/17/26
See full
Market cap$224.6M-38.7%
Enterprise value$221.83M-34.4%
P/S1.8×-0.7×

Profitability

See full
Operating margin-43.2%+42.1pp
Net margin-36.8%+77.5pp
FCF margin-21.3%+21.3pp

Returns & leverage

See full
Return on equity-17.3%+16.5pp
Debt / equity0×0.0×
Current ratio4.1×-9.9×

Segments

By product

See full
Rxlal$24.5M-9.3%
Service Warranty Service Contracts And Accessories$1.4M-6.3%
LDD$1.3M-73.9%

FAQ

When did RxSight, Inc. report Q2 2026 earnings?
RxSight, Inc. (RXST) reported Q2 2026 earnings on August 5, 2026 after market close.
What were RxSight, Inc.'s Q2 2026 revenue and EPS?
RxSight, Inc. reported revenue of $33.7M and eps of $-0.29 for Q2 2026.
Did RxSight, Inc. beat estimates in Q2 2026?
Revenue beat the consensus estimate of $32.5M by $1.2M. EPS beat the consensus estimate of $-0.33 by $0.04.
How did RxSight, Inc.'s Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 0.3% from $33.6M a year earlier and eps declined 262.5% from $-0.08.
Where can I find RxSight, Inc.'s Q2 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-335150) and the 10-Q periodic report (0001193125-26-335153) directly on SEC EDGAR. The filing index links above go to sec.gov.